UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Graefe's archive for clinical and experimental ophthalmology, 2008-01, Vol.246 (1), p.81-87

2008

Volltextzugriff (PDF)

Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy

Current diabetes reports, 2019-10, Vol.19 (10), p.106-5, Article 106

2019

Volltextzugriff (PDF)

Surgery for Diabetic Eye Complications

Current Diabetes Reports, 2016-10, Vol.16 (10), p.99-99, Article 99

2016

Volltextzugriff (PDF)

Clinical comparison of 27-gauge and 23-gauge instruments on the outcomes of pars plana vitrectomy surgery for the treatment of vitreoretinal diseases

Current opinion in ophthalmology, 2020-05, Vol.31 (3), p.185

2020

Volltextzugriff (PDF)

Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy

Journal of clinical medicine, 2024-05, Vol.13 (10), p.2778

2024

Volltextzugriff (PDF)

Long-Term Outcomes of Same Patient Eyes Treated with Pars Plana Vitrectomy in One Eye and Conventional Treatment in the Other for Complications of Proliferative Diabetic Retinopathy

Journal of clinical medicine, 2022-09, Vol.11 (18), p.5399

2022

Volltextzugriff (PDF)

INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: 5-Year Results of The Pan-American Collaborative Retina Study Group

Retina (Philadelphia, Pa.), 2016-05, Vol.36 (5), p.859

2016

Volltextzugriff (PDF)

Minimal, Relaxing Membranectomies for the Management of Opacified Hyaloid With Diabetic Tractional Retinal Detachments in Monocular Patients: A Novel Surgical Technique

Retina (Philadelphia, Pa.), 2023-12, Vol.43 (12), p.2144

2023

Volltextzugriff (PDF)

Management of Giant Retinal Tear Detachments

Journal of ophthalmic & vision research, 2017-01, Vol.12 (1), p.93-97

2017

Volltextzugriff (PDF)

Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group

British journal of ophthalmology, 2018-04, Vol.102 (4), p.455

2018

Volltextzugriff (PDF)

Clinical Course of Vitreomacular Traction Managed Initially by Observation

Ophthalmic surgery, lasers & imaging retina, 2015-05, Vol.46 (5), p.571

2015

Volltextzugriff (PDF)

Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti-VEGF Intravitreal Injections: Results from the Pan-American Collaborative Retina Study (PACORES) Group

Journal of ophthalmology, 2021-10, Vol.2021, p.5591865-7

2021

Volltextzugriff (PDF)

Sub-internal limiting membrane hemorrhage associated with Weil's disease

American journal of ophthalmology case reports, 2019-12, Vol.16, p.100546, Article 100546

2019

Volltextzugriff (PDF)

Twenty-seven-gauge vitrectomy for combined tractional and rhegmatogenous retinal detachment involving the macula associated with proliferative diabetic retinopathy

International journal of retina and vitreous, 2017-10, Vol.3 (1), p.38-38, Article 38

2017

Volltextzugriff (PDF)

Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up

Graefe's archive for clinical and experimental ophthalmology, 2009-06, Vol.247 (6), p.735-743

2009

Volltextzugriff (PDF)

Surgical management of retinal diseases: proliferative diabetic retinopathy and traction retinal detachment

Developments in ophthalmology, 2014-01, Vol.54, p.196

2014

Volltextzugriff (PDF)

Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

American journal of ophthalmology, 2019-08, Vol.204, p.13-18

2019

Volltextzugriff (PDF)

Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study

Ophthalmology (Rochester, Minn.), 2010-10, Vol.117 (10), p.1974-1981.e1

2010

Volltextzugriff (PDF)

Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease

Ophthalmology (Rochester, Minn.), 2018-03, Vol.125 (3), p.423-431

2018

Volltextzugriff (PDF)

Retinal Detachment after Bevacizumab

Ophthalmology (Rochester, Minn.), 2011-11, Vol.118 (11), p.2304.e3-2304.e7

2011

Volltextzugriff (PDF)

Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease

American journal of ophthalmology, 2016-01, Vol.161, p.36-43.e2

2016

Volltextzugriff (PDF)

Primary intravitreal bevacizumab (avastin) for diabetic macular edema : Results from the pan-american collaborative retina study group at 6-month follow-up

Ophthalmology (Rochester, Minn.), 2007-04, Vol.114 (4), p.743-750

2007

Volltextzugriff (PDF)

Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group

British journal of ophthalmology, 2018-12, Vol.102 (12), p.1696

2018

Volltextzugriff (PDF)

Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia

Retina (Philadelphia, Pa.), 2008-02, Vol.28 (2), p.314

2008

Volltextzugriff (PDF)

Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema

Acta ophthalmologica (Oxford, England), 2012-03, Vol.90 (2), p.e160-e161

2012

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(66)
Humans
(62)
Ophthalmology
(59)
Female
(50)
Male
(49)
Middle Aged
(44)
Retrospective Studies
(41)
Aged
(40)
Adult
(28)
Tomography, Optical Coherence
(26)
Treatment Outcome
(24)
Vascular Endothelial Growth Factor A - Antagonists & Inhibitors
(22)
Visual Acuity - Physiology
(22)
Bevacizumab
(21)
Follow-Up Studies
(19)
Aged, 80 And Over
(17)
Visual Acuity
(17)
Fluorescein Angiography
(16)
Angiogenesis Inhibitors - Administration & Dosage
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy

Surgery for Diabetic Eye Complications

Clinical comparison of 27-gauge and 23-gauge instruments on the outcomes of pars plana vitrectomy surgery for the treatment of vitreoretinal diseases

Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy

Long-Term Outcomes of Same Patient Eyes Treated with Pars Plana Vitrectomy in One Eye and Conventional Treatment in the Other for Complications of Proliferative Diabetic Retinopathy

INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: 5-Year Results of The Pan-American Collaborative Retina Study Group

Minimal, Relaxing Membranectomies for the Management of Opacified Hyaloid With Diabetic Tractional Retinal Detachments in Monocular Patients: A Novel Surgical Technique

Management of Giant Retinal Tear Detachments

Intravitreal bevacizumab monotherapy in myopic choroidal neovascularisation: 5-year outcomes for the PAN-American Collaborative Retina Study Group

Clinical Course of Vitreomacular Traction Managed Initially by Observation

Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti-VEGF Intravitreal Injections: Results from the Pan-American Collaborative Retina Study (PACORES) Group

Sub-internal limiting membrane hemorrhage associated with Weil's disease

Twenty-seven-gauge vitrectomy for combined tractional and rhegmatogenous retinal detachment involving the macula associated with proliferative diabetic retinopathy

Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up

Surgical management of retinal diseases: proliferative diabetic retinopathy and traction retinal detachment

Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions

Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study

Long-Term Visual Outcomes and Safety Profile of 27-Gauge Pars Plana Vitrectomy for Posterior Segment Disease

Retinal Detachment after Bevacizumab

Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease

Primary intravitreal bevacizumab (avastin) for diabetic macular edema : Results from the pan-american collaborative retina study group at 6-month follow-up

Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group

Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia

Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema

Suchergebnisse filtern